MERCK has announced an expansion of its distribution alliance with Public Health England, to include the European Bank of induced pluripotent Stem Cells (EBiSC) - a cell bank of over 300 quality-controlled disease-relevant patient-derived human cell lines.
The global distribution agreement includes all geographies except Japan and will see Merck use its sales, marketing and e-commerce expertise to distribute the EBiSC Human iPS Cell Bank.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 17